BIO-Europe 201710 November 2017
The annual Bio-Europe 2017, which took place in Berlin this year, is an excellent environment to meet start-ups and potential investors in the biotech industry. At this global conference, Primer Capital was looking for new opportunities to invest in promising developments and new co-investment partners.
In 3 days we held more than 30 meetings to present our fund and exchanged portfolios with potential partners, including German, American and British investors, as well as one of the leading Big Pharma companies.
During our meetings, we reviewed scientific and investment potential of start-ups and started to discuss further steps with the most interesting projects.